Ionis Pharmaceuticals Inc (NAS:IONS)
$ 35.91 -0.42 (-1.16%) Market Cap: 5.74 Bil Enterprise Value: 4.73 Bil PE Ratio: 0 PB Ratio: 8.65 GF Score: 40/100

Q3 2020 Ionis Pharmaceuticals Inc Earnings Call Transcript

Nov 04, 2020 / 04:30PM GMT
Release Date Price: $47.61 (+1.30%)
Operator

Good morning, and welcome to the Ionis Pharmaceuticals Third Quarter 2020 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to Wade Walke, Vice President, Investor Relations, to lead off the call. Please go ahead.

D. Wade Walke
Ionis Pharmaceuticals, Inc. - VP of IR

Thank you, Brandon. Before we begin, I encourage everyone to go to the Investors section of the Ionis website to find the press release and related financial tables, including a reconciliation of GAAP to non-GAAP financial measures that we will discuss today. We believe non-GAAP financial results better represent the economics of our business and how we manage our business. We have also posted slides on our website that accompany our discussion today.

With me on today's call are Brett Monia, our Chief Executive Officer; Beth Hougen, Chief Financial Officer; Onaiza Cadoret, our Chief Corporate Development and Commercial Officer; and Richard Geary, Executive Vice President of Development. And joining us for Q&A

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot